Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.5 EUR | -0.95% | +3.67% | +38.54% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |